These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 28971485)

  • 1. Evolution of the serologic and virologic course of occult HBV infection in therapy experienced HIV co-infected patients.
    Amponsah-Dacosta E; Selabe SG; Mphahlele MJ
    J Med Virol; 2018 Feb; 90(2):291-303. PubMed ID: 28971485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virological characteristics of occult hepatitis B virus in a North American cohort of human immunodeficiency virus type 1-positive patients on dual active anti-HBV/HIV therapy.
    Coffin CS; Mulrooney-Cousins PM; Osiowy C; van der Meer F; Nishikawa S; Michalak TI; van Marle G; Gill MJ
    J Clin Virol; 2014 Aug; 60(4):347-53. PubMed ID: 24881491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence of susceptibility to lamivudine-based HAART and genetic stability of hepatitis B virus (HBV) in HIV co-infected patients: A South African longitudinal HBV whole genome study.
    Amponsah-Dacosta E; Rakgole JN; Gededzha MP; Lukhwareni A; Blackard JT; Selabe SG; Mphahlele MJ
    Infect Genet Evol; 2016 Sep; 43():232-8. PubMed ID: 27245151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High prevalence of occult hepatitis B infection in an African urban population.
    Apica BS; Seremba E; Rule J; Yuan HJ; Lee WM
    J Med Virol; 2016 Apr; 88(4):674-80. PubMed ID: 26334654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overt and occult hepatitis B virus infection among treatment-naïve HIV-infected patients in Brazil.
    Oliveira MP; Lemes PS; Matos MA; Del-Rios NH; Carneiro MA; Silva ÁM; Lopes CL; Teles SA; Aires RS; Lago BV; Araujo NM; Martins RM
    J Med Virol; 2016 Jul; 88(7):1222-9. PubMed ID: 27061406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Occult hepatitis B infection in patients infected with HIV: report of two cases of hepatitis B reactivation and prevalence in a hospital cohort.
    Bloquel B; Jeulin H; Burty C; Letranchant L; Rabaud C; Venard V
    J Med Virol; 2010 Feb; 82(2):206-12. PubMed ID: 20029819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased detection of HBV DNA in HBsAg-positive and HBsAg-negative South African HIV/AIDS patients enrolling for highly active antiretroviral therapy at a Tertiary Hospital.
    Lukhwareni A; Burnett RJ; Selabe SG; Mzileni MO; Mphahlele MJ
    J Med Virol; 2009 Mar; 81(3):406-12. PubMed ID: 19152393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of occult hepatitis B virus infection among HIV positive patients in Cameroon.
    Gachara G; Magoro T; Mavhandu L; Lum E; Kimbi HK; Ndip RN; Bessong PO
    AIDS Res Ther; 2017 Mar; 14(1):11. PubMed ID: 28270215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis B virus nucleic acid amplification testing of Australian blood donors highlights the complexity of confirming occult hepatitis B virus infection.
    Kiely P; Margaritis AR; Seed CR; Yang H;
    Transfusion; 2014 Aug; 54(8):2084-91. PubMed ID: 24650170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Occult hepatitis B virus infection in Greek patients with congenital bleeding disorders.
    Varaklioti A; Kouramba A; Ioannidou P; Katsarou O
    Infect Genet Evol; 2017 Oct; 54():397-401. PubMed ID: 28705716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Occult hepatitis B virus infection before and 1 year after start of HAART in HIV type 1-positive patients.
    Pogány K; Zaaijer HL; Prins JM; Wit FW; Lange JM; Beld MG
    AIDS Res Hum Retroviruses; 2005 Nov; 21(11):922-6. PubMed ID: 16386107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of chronic hepatitis B virus infection in hepatitis B surface antigen negative HIV/HBV co-infected adults: a rare opportunistic illness.
    Landrum ML; Roediger MP; Fieberg AM; Weintrob AC; Okulicz JF; Crum-Cianflone NF; Ganesan A; Lalani T; Macalino GE; Chun HM
    J Med Virol; 2011 Sep; 83(9):1537-43. PubMed ID: 21739443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Occult hepatitis B and HIV infection.
    Soriano V; Aguilera A; Gonzalez R; Gomez-Gallego F; Barea L; Treviño M; Corral O
    Eur J Gastroenterol Hepatol; 2019 Nov; 31(11):1403-1407. PubMed ID: 30969194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Occult hepatitis B virus infection in ART-naive HIV-infected patients seen at a tertiary care centre in north India.
    Gupta S; Singh S
    BMC Infect Dis; 2010 Mar; 10():53. PubMed ID: 20205948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Investigation of occult hepatitis B in HIV infected patients].
    Altınbaş A; Ergünay K; Calık Başaran N; Alp A; Turgut D; Hasçelik G; Uzun Ö; Unal S
    Mikrobiyol Bul; 2011 Apr; 45(2):353-8. PubMed ID: 21644079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High risk of occult hepatitis B virus infection in HIV-positive patients from South Africa.
    Mphahlele MJ; Lukhwareni A; Burnett RJ; Moropeng LM; Ngobeni JM
    J Clin Virol; 2006 Jan; 35(1):14-20. PubMed ID: 15916918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular analysis of hepatitis B virus (HBV) in an HIV co-infected patient with reactivation of occult HBV infection following discontinuation of lamivudine-including antiretroviral therapy.
    Costantini A; Marinelli K; Biagioni G; Monachetti A; Ferreri ML; Butini L; Montroni M; Manzin A; Bagnarelli P
    BMC Infect Dis; 2011 Nov; 11():310. PubMed ID: 22054111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Occult hepatitis B virus infection in Korean patients with isolated anti-HBc.
    Kang SY; Kim MH; Lee WI
    Arch Virol; 2014 Feb; 159(2):227-33. PubMed ID: 23933720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns of hepatitis B virus infection in Brazilian human immunodeficiency virus infected patients: high prevalence of occult infection and low frequency of lamivudine resistant mutations.
    Sucupira MV; Mello FC; Santos EA; Niel C; Rolla VC; Arabe J; Gomes SA
    Mem Inst Oswaldo Cruz; 2006 Sep; 101(6):655-60. PubMed ID: 17072479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of Hepatitis B Virus DNA among Chronic and potential Occult HBV patients in resource-limited settings by Loop-Mediated Isothermal Amplification assay.
    Akram A; Islam SMR; Munshi SU; Tabassum S
    J Viral Hepat; 2018 Nov; 25(11):1306-1311. PubMed ID: 29768691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.